Anavex Life Sciences To Present New Preclinical Data At The 20th Annual Meeting Of The American Society For Experimental Neurotherapeutics Asent | Latest News RSS feed

Anavex Life Sciences To Present New Preclinical Data At The 20th Annual Meeting Of The American Society For Experimental Neurotherapeutics Asent - Latest News


Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)

ANAVEX®2-73 Extends Survival and Reduces Seizures in an Orphan Disease Model NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a ... read more

Add your link right here

Add your story here to improve SEO, search ranking and drive traffic to your website. Your link will be permanently featured right on this page. To add a link on diferent page, just visit the page you want to show your link and click "Add your link right here". You can use search form below to find the page. read more

Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)

March 07, 2018 07:00 ET | Source: Anavex Life Sciences Corp. ANAVEX®2-73 Extends Survival and Reduces Seizures in an Orphan Disease Model NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- Anavex Life ... read more

Anavex Life Sciences to Present at the 30th Annual ROTH Conference

NEW YORK, March 09 ... today announced that the Company will present at the 30 th Annual ROTH Conference on Tuesday, March 13 th at 8:30 am PDT in Dana Point, CA. About Anavex Life Sciences Corp. ... read more

Looking for another news?


Anavex Life Sciences to Present at the 30th Annual ROTH Conference

NEW YORK, March 09 ... today announced that the Company will present at the 30 th Annual ROTH Conference on Tuesday, March 13 th at 8:30 am PDT in Dana Point, CA. About Anavex Life Sciences Corp. ... read more


Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)

NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us